Drug name - Cequa

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8980839 SUN PHARM Topical aqueous nanomicellar, ophthalmic solutions and uses thereof Aug, 2033

(10 years from now)

US9937225 SUN PHARM Topical formulations and uses thereof Aug, 2033

(10 years from now)

US10441630 SUN PHARM Topical formulations and uses thereof Aug, 2033

(10 years from now)

US10918694 SUN PHARM Topical cyclosporine-containing formulations and uses thereof Feb, 2037

(14 years from now)

Drugs and Companies using CYCLOSPORINE ingredient

Treatment: Increase tear production in patients with keratoconjunctivitis sicca (dry eye).

Dosage: SOLUTION;OPHTHALMIC

More Information on Dosage
Strength Dosage Availability
0.09% SOLUTION;OPHTHALMIC Prescription

availability in other generic markets.

Click on the highlighted region to filter.